These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9537683)

  • 1. Dopaminergic activity and the discriminative stimulus effects of mu opioids in pigeons: importance of training dose and attenuation by the D3 agonist (+/-)-7-OH-DPAT.
    Cook CD; Picker MJ
    Psychopharmacology (Berl); 1998 Mar; 136(1):59-69. PubMed ID: 9537683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective attenuation of the antinociceptive effects of mu opioids by the putative dopamine D3 agonist 7-OH-DPAT.
    Cook CD; Rodefer JS; Picker MJ
    Psychopharmacology (Berl); 1999 Jun; 144(3):239-47. PubMed ID: 10435390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminative stimulus effects of butorphanol: influence of training dose on the substitution patterns produced by Mu, Kappa and Delta opioid agonists.
    Picker MJ; Benyas S; Horwitz JA; Thompson K; Mathewson C; Smith MA
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1130-41. PubMed ID: 8968334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus effects of opioids in pigeons trained to discriminate fentanyl, bremazocine and water: evidence of pharmacological selectivity.
    Picker MJ; Cook CD
    Behav Pharmacol; 1997 Jun; 8(2-3):160-73. PubMed ID: 9833011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative stimulus effects of the mixed-opioid agonist/antagonist dezocine: cross-substitution by mu and delta opioid agonists.
    Picker MJ
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1009-17. PubMed ID: 9399970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delta opioid-like discriminative stimulus effects of mu opioids in pigeons discriminating the delta opioid BW373U86 from saline.
    Picker MJ; Cook CD
    Behav Pharmacol; 1998 Jul; 9(4):319-28. PubMed ID: 10065920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of D2 and D3 receptor-selective ligands in rats trained to discriminate cocaine from saline.
    Garner KJ; Baker LE
    Pharmacol Biochem Behav; 1999 Oct; 64(2):373-8. PubMed ID: 10515316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the discriminative stimulus effects of mu opioid agonists in rats: II. Effects of dopamine D2/3 agonists.
    Cook CD; Beardsley PM
    Behav Pharmacol; 2004 Feb; 15(1):75-83. PubMed ID: 15075629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dopamine D3 receptor antagonist PNU-99194A fails to block (+)-7-OH-DPAT substitution for D-amphetamine or cocaine.
    Baker LE; Svensson KA; Garner KJ; Goodwin AK
    Eur J Pharmacol; 1998 Oct; 358(2):101-9. PubMed ID: 9808258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of mu-opioid agonists on cocaine- and food-maintained responding and cocaine discrimination in rhesus monkeys: role of mu-agonist efficacy.
    Negus SS; Mello NK
    J Pharmacol Exp Ther; 2002 Mar; 300(3):1111-21. PubMed ID: 11861822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dopamine D3/2 agonist 7-OH-DPAT attenuates the development of morphine tolerance but not physical dependence in rats.
    Cook CD; Barrett AC; Syvanthong C; Picker MJ
    Psychopharmacology (Berl); 2000 Sep; 152(1):93-104. PubMed ID: 11041321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of D3 versus D2 receptor modulation of the discriminative stimulus effects of (+)-7-OH-DPAT in rats.
    Baker LE; Hood CA; Heidema AM
    Behav Pharmacol; 1999 Dec; 10(8):717-22. PubMed ID: 10780286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminative stimulus effects of putative D3 dopamine receptor agonists in rats.
    Katz JL; Alling KL
    Behav Pharmacol; 2000 Sep; 11(6):483-93. PubMed ID: 11103914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine D2/D3 receptors modulate cocaine's reinforcing and discriminative stimulus effects in rhesus monkeys.
    Sinnott RS; Mach RH; Nader MA
    Drug Alcohol Depend; 1999 Apr; 54(2):97-110. PubMed ID: 10217549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
    Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-choice discrimination in pigeons is based on relative efficacy differences among opioids.
    Walker EA; Picker MJ; Dykstra LA
    Psychopharmacology (Berl); 2001 Jun; 155(4):389-96. PubMed ID: 11441428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mu opioid irreversible antagonist beta-funaltrexamine differentiates the discriminative stimulus effects of opioids with high and low efficacy at the mu opioid receptor.
    Morgan D; Picker MJ
    Psychopharmacology (Berl); 1998 Nov; 140(1):20-8. PubMed ID: 9862398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic involvement in the discriminative-stimulus effects of methamphetamine in rats.
    Munzar P; Goldberg SR
    Psychopharmacology (Berl); 2000 Feb; 148(2):209-16. PubMed ID: 10663437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of dopamine D3 and D4 receptors in the discriminative stimulus properties of cocaine in the rat.
    Ukai M; Mitsunaga H
    Methods Find Exp Clin Pharmacol; 2005 Nov; 27(9):645-9. PubMed ID: 16357950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulatory effects of dopamine D3/2 agonists on kappa opioid-induced antinociception and diuresis in the rat.
    Cook CD; Barrett AC; Syvanthong C; Picker MJ
    Psychopharmacology (Berl); 2000 Sep; 152(1):14-23. PubMed ID: 11041311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.